COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 487: Articles 4861-4870  | Next

Can Koreans be 'FREE' from mask wearing?: Advanced mathematical model can suggest the idea
Ko, Y., Mendoza, V. M., Mendoza, R., Seo, Y. B., Lee, J., Jung, E.
10.1101/2023.01.03.23284126 — Posted: 2023-01-07
Significance of Wastewater Surveillance in Detecting the Prevalence of SARS-CoV-2 Variants and Other Respiratory Viruses in the Community-A Multi-Site Evaluation
Khan, M., Li, L., Haak, L., Harger, S., Carine, M., Adhikari, K., Uppal, T., Hartley, P., Vasquez-Gross, H., Petereit, J., Verma, S. C., Pagilla, K. R.
10.1101/2023.01.05.23284236 — Posted: 2023-01-07
CASCADIA: A prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults utilizing a remote nasal swab collection and web-based survey design
Babu, T. M., Feldstein, L. R., Saydah, S., Acker, Z., Boisvert, C. L., Briggs-Hagen, M., Carone, M., Casto, A., Cox, S. N., Ehmen, B., Englund, J. A., Fortmann, S. P., Frivold, C. J., Groom, H., Han, P., Kuntz, J. L., Lockwood, T., Midgley, C. M., Mularski, R. A., Ogilvie, T., Reich, S., Schmidt, M. A., Smith, N., Starita, L., Stone, J., Vandermeer, M., Weil, A., Wolf, C. R., Chu, H. Y., Naleway, A. L.
10.1101/2023.01.05.22283913 — Posted: 2023-01-07
Counting Cases and Deaths by Age Tells Us About COVID-19 Infectious and Lethal Components
Michaelson, J. S.
10.1101/2023.01.05.23284239 — Posted: 2023-01-07
Nursing Intervention Analysis in COVID-19 Negative Pressure Isolation Wards and General Wards: Observational study
Kim, H. H., Park, H., Lee, M. s., Lee, G. M., Oh, H., Hwangbo, S., Roh, S.
10.1101/2023.01.06.23284223 — Posted: 2023-01-07
Oral Azvudine (FNC) Tablets in Patients infected with SARS-CoV-2 Omicron Variant: A Retrospective Cohort Study
Chen, W., Xu, H., Hong, L., Yang, R., Peng, C., Wang, G., Li, W.
10.1101/2023.01.05.23284180 — Posted: 2023-01-06
Omicron Spike Protein Is Vulnerable to Reduction
Stagljar, I., Yao, Z., Geng, B., Marcon, E., Pu, S., Tang, H., Merluza, J., Bello, A., Snider, J., Lu, P., Wood, H.
10.1101/2023.01.06.522977 — Posted: 2023-01-06
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides
Llewellyn, G. N., Chen, H.-Y., Rogers, G. L., Huang, X., Sell, P., Henley, J. E., Cannon, P. M.
10.1101/2023.01.05.522964 — Posted: 2023-01-06
Direct comparison of clinical diagnostic sensitivity of saliva from buccal swabs versus combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 B.1.1.529 Omicron
Puyskens, A., Michel, J., Stoliaroff-Pepin, A., Bayram, F., Sesver, A., Wichmann, O., Harder, T., Schaade, L., Nitsche, A., Peine, C.
10.1101/2023.01.05.23284222 — Posted: 2023-01-06
Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variant
Karyakarte, R., Das, R., Dudhate, S., Agarasen, J., Pillai, P., Chandankhede, P., Labhshetwar, R., Gadiyal, Y., Rajmane, M., Kulkarni, P., Nizarudeen, S., Joshi, S., Potdar, V., Karmodiya, K.
10.1101/2023.01.05.23284211 — Posted: 2023-01-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).